Union Minister of State (Independent Charge) for Science and Technology Dr Jitendra Singh launched the GEMCOVAC® -OM, an Omicron-specific mRNA-based Booster vaccine.
- India’s first mRNA vaccine has been developed using the indigenous platform technology by Gennova, with funding support from Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC).
- GEMCOVAC® -OM is a thermostable vaccine and does not require ultra-cold chain infrastructure used for other approved mRNA- based vaccines.
- The GEMCOVAC® -OM vaccine is delivered intra-dermally using a needle-free injection device system and in study participants it generated significantly higher immune responses.
